Diabetes is a midlife risk factor for later dementia in the 2026 WHO dementia guideline, and WHO recommends diabetes care with medications, lifestyle changes, or both for adults with diabetes to lower risk of cognitive decline and dementia. Cognitive decline means a loss of memory and thinking skills that interferes with daily life, and dementia is its most severe form. Access and adherence gaps in midlife blunt that protection.
WHO published the second edition of its risk-reduction guideline on 15 July 2026, as described in the July 2026 WHO announcement. The update takes a life-course approach for adults without dementia. Diabetes sits alongside hypertension, high cholesterol, inactivity, smoking, isolation, and air pollution as a major modifiable factor.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the original report from Who — Use this primary source to review the complete report.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- What the guideline recommends for diabetes
- Why midlife treatment gaps matter
- What blocks access and steady use
- How can adults in midlife stay on track
What the guideline recommends for diabetes
WHO recommends that adults who have diabetes be offered management with medications, lifestyle interventions, or both to reduce cognitive risk. The advice is risk reduction, not a cure or guarantee against dementia. Treatment of blood sugar works as part of broader vascular and brain health.
Exposure in midlife, roughly ages 40 to 65, shapes later cognitive risk. Control during these years matters more than late action alone. That timing makes missed diagnosis and interrupted treatment especially costly.
Why midlife treatment gaps matter
Global adult diabetes prevalence rose from 7% to 14% between 1990 and 2022, WHO reported in the November 2024 diabetes update. In 2022 almost 450 million adults aged 30 and older remained untreated. The largest gaps were in low- and middle-income countries.
More than half of people living with diabetes did not take diabetes medication in 2022. Coverage was lowest in low- and middle-income countries. For adults in midlife, each untreated year extends the exposure linked to later dementia.
What blocks access and steady use
WHO maps universal insulin and diabetes-care barriers as high prices, low availability of human insulin, domination by a few producers, and weak health systems, detailed in the 2021 WHO insulin-access report. Medicine and diagnostic shortages add further breaks in care. These barriers hit hardest where treatment coverage is already lowest.
Adherence also fails when refills, monitoring supplies, and follow-up visits are unreliable. Costs force dose skipping, delayed refills, and missed checks. Long gaps in midlife undo steady glycaemic and blood-pressure control.
How can adults in midlife stay on track
Ask a clinician whether you need diabetes testing, medication, a lifestyle plan, or a combination. Bring a list of current drugs, blood-pressure readings, and missed doses.
Ask what to do when a drug or test strip is out of stock. The 45% dementia figure is a theoretical population estimate if risks were fully removed, not a personal promise. WHO 2030 diabetes targets aim for 80% diagnosed, 80% with glycaemic and blood-pressure control, 60% of those 40 and older on statins, and affordable insulin plus self-monitoring for everyone with type 1 diabetes.
- Confirm diagnosis, target ranges, and review dates for blood sugar and blood pressure
- Ask about statin use if you are 40 or older and have diabetes
- Plan refills, low-cost options, and self-monitoring supplies before you run out
- Track doses taken, missed doses, and side effects to review at each visit
You Might Also Like
- Air Pollution in the 2026 WHO Dementia Guideline: Access and Adherence Barriers for Adults in Midlife
- Healthy Diets in the 2026 WHO Dementia Guidelines: What the Evidence Supports and What It Does Not
- Healthy Diets in the 2026 WHO Dementia Guidelines: Practical Steps Families Can Discuss With a Clinician
